A Bayesian population-based framework for detecting hyperprogressive disease on cancer immunotherapies.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: GlaxoSmithKline (United Kingdom)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410809837
